Literature DB >> 7933091

Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease.

F P Thomas1, C Chalk, R Lalonde, Y Robitaille, P Jolicoeur.   

Abstract

Patients infected with the human immunodeficiency virus type 1 (HIV-1) frequently develop central and peripheral nervous system complications, some of which may reflect the effect of the virus itself. In order to elucidate the pathogenic mechanisms of HIV in neurological disease in a small animal model, we generated transgenic mice expressing the entire HIV genome under control of the promoter for the human neurofilament NF-L gene. The transgene was predominantly expressed in anterior thalamic and spinal motor neurons. Animals developed a neurological syndrome characterized by hypoactivity and weakness and by axonal degeneration in peripheral nerves. These results provide evidence for a role of HIV in affecting both the central and peripheral nervous systems. This animal model may also facilitate the development of therapeutic agents against the human disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933091      PMCID: PMC237148     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Behaviour deficits following diencephalic lesions.

Authors:  J S MEYER; J HUNTER
Journal:  Neurology       Date:  1952 Mar-Apr       Impact factor: 9.910

2.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

3.  Necrotizing vasculitis and HIV replication in peripheral nerves.

Authors:  R Gherardi; F Lebargy; P Gaulard; C Mhiri; J F Bernaudin; F Gray
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

4.  Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist.

Authors:  J R Glowa; L V Panlilio; D E Brenneman; I Gozes; M Fridkin; J M Hill
Journal:  Brain Res       Date:  1992-01-20       Impact factor: 3.252

5.  Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

Authors:  D E Brenneman; G L Westbrook; S P Fitzgerald; D L Ennist; K L Elkins; M R Ruff; C B Pert
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

6.  Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

Authors:  D Giulian; K Vaca; C A Noonan
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

7.  Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier.

Authors:  F P Thomas; W Trojaborg; C Nagy; M Santoro; S A Sadiq; N Latov; A P Hays
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 8.  Peripheral neuropathies associated with human immunodeficiency virus infection.

Authors:  D M Simpson; R K Olney
Journal:  Neurol Clin       Date:  1992-08       Impact factor: 3.806

9.  Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Authors:  D D Ho; T R Rota; R T Schooley; J C Kaplan; J D Allan; J E Groopman; L Resnick; D Felsenstein; C A Andrews; M S Hirsch
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

10.  Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.

Authors:  C L Achim; M P Heyes; C A Wiley
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more
  18 in total

Review 1.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors.

Authors:  Cleve O James; Ming-Bo Huang; Mafuz Khan; Minerva Garcia-Barrio; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Characterization of Nef-CXCR4 interactions important for apoptosis induction.

Authors:  Ming-Bo Huang; Ling Ling Jin; Cleve O James; Mahfuz Khan; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 4.  Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury.

Authors:  Ricky Maung; Kathryn E Medders; Natalia E Sejbuk; Maya K Desai; Rossella Russo; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

Review 5.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

Review 6.  Schwann cells as a therapeutic target for peripheral neuropathies.

Authors:  Helmar C Lehmann; Ahmet Höke
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

Review 7.  Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.

Authors:  G A Cabral; L Griffin-Thomas
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-09       Impact factor: 2.895

8.  Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Mehrnush Kalayeh; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 9.  Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.

Authors:  Christopher Power; Elizabeth Hui; Pornpun Vivithanaporn; Shaona Acharjee; Maria Polyak
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-15       Impact factor: 4.147

10.  Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alterations.

Authors:  F Berrada; D Ma; J Michaud; G Doucet; L Giroux; A Kessous-Elbaz
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.